Effect of denosumab administration on low bone mineral density ( T -score −1.0 to −2.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer
In conclusion, semi-annual treatment with denosumab was associated with increased BMD in Japanese women receiving adjuvant AI therapy, rega rdless of prior AI treatment.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research
More News: Breast Cancer | Calcium | Cancer | Cancer & Oncology | Endocrine Therapy | Hormones | Japan Health | Orthopaedics | Osteoporosis | Study | Vitamin D | Vitamins | Women | Xgeva